Improving hepatitis B vaccination rates in newborns in Nigeria
Research Project 2
This study is all about finding better ways to help newborns in Nigeria get their hepatitis B vaccine right after birth, so they can stay healthy and avoid serious liver problems, and it involves working closely with local communities and healthcare providers to come up with effective solutions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-10931751 on NIH RePORTER |
What this research studies
This research aims to enhance the uptake of the hepatitis B birth dose (HepB-BD) vaccine in Nigeria, which is crucial for preventing hepatitis B virus (HBV) infections and related liver diseases. The project will utilize a crowdsourcing approach to develop and implement strategies that promote timely vaccination at community clinics and home births. By engaging local communities and healthcare providers, the research seeks to identify effective solutions to increase vaccination rates among newborns. The study will also apply the Consolidated Framework for Implementation Science to ensure that the strategies are relevant and sustainable.
Who could benefit from this research
Good fit: Ideal candidates for this research are newborns in Nigeria who are at risk of hepatitis B infection and their mothers, particularly those receiving care outside of hospital settings.
Not a fit: Patients who are already vaccinated against hepatitis B or those who do not reside in Nigeria may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the incidence of hepatitis B and liver cancer in newborns, leading to improved health outcomes in affected communities.
How similar studies have performed: Previous research has successfully utilized crowdsourcing to improve health outcomes in low and middle-income countries, indicating that this approach has potential for success.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Iwelunmor, Juliet — Washington University
- Study coordinator: Iwelunmor, Juliet
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.